serine has been researched along with toyocamycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, YH; Kim, MK; Lee, CH; Moon, SI; Park, HY | 1 |
1 other study(ies) available for serine and toyocamycin
Article | Year |
---|---|
Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53/p21WAF1/CIP1 pathway.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Humans; Male; Phosphorylation; Prostatic Neoplasms; Serine; Signal Transduction; Toyocamycin; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2006 |